Huntington National Bank Biomarin Pharmaceutical Inc Transaction History

Huntington National Bank

$13.4 Billion
Q1 2025

A detailed history of Huntington National Bank transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Huntington National Bank holds 500 shares of BMRN stock, worth $29,055. This represents 0.0% of its overall portfolio holdings.

Number of Shares

500

Previous 515 2.91%

Holding current value

$29,055

Previous $33,000 6.06%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$61.25 - $72.83 $918 - $1,092	-15 Reduced 2.91%	500 $35,000
Q4 2024 Feb 12, 2025	SELL	$61.93 - $70.49 $3,591 - $4,088	-58 Reduced 10.12%	515 $33,000
Q3 2024 Nov 06, 2024	BUY	$69.02 - $93.84 $759 - $1,032	11 Added 1.96%	573 $40,000
Q2 2024 Aug 08, 2024	SELL	$74.43 - $92.22 $6,028 - $7,469	-81 Reduced 12.6%	562 $46,000
Q1 2024 May 03, 2024	BUY	$83.81 - $99.0 $44,586 - $52,668	532 Added 479.28%	643 $56,000
Q4 2023 Feb 07, 2024	BUY	$76.22 - $98.51 $3,506 - $4,531	46 Added 70.77%	111 $10,000
Q3 2023 Nov 08, 2023	SELL	$85.07 - $94.48 $2,722 - $3,023	-32 Reduced 32.99%	65 $5,000
Q2 2023 Aug 11, 2023	BUY	$86.68 - $100.3 $4,767 - $5,516	55 Added 130.95%	97 $8,000
Q1 2023 May 10, 2023	BUY	$87.74 - $117.27 $3,597 - $4,808	41 Added 4100.0%	42 $4,000
Q4 2022 Feb 09, 2023	SELL	$80.93 - $108.63 $890 - $1,194	-11 Reduced 91.67%	1 $0
Q3 2022 Nov 07, 2022	SELL	$82.16 - $96.94 $13,885 - $16,382	-169 Reduced 93.37%	12 $0
Q2 2022 Aug 09, 2022	BUY	$71.48 - $86.85 $12,080 - $14,677	169 Added 1408.33%	181 $14,000
Q4 2021 Jan 21, 2022	BUY	$71.72 - $91.47 $71 - $91	1 Added 9.09%	12 $0
Q1 2020 Apr 27, 2020	SELL	$71.37 - $96.85 $12,347 - $16,755	-173 Reduced 94.02%	11 $0
Q4 2019 Jan 17, 2020	BUY	$64.27 - $86.37 $7,969 - $10,709	124 Added 206.67%	184 $15,000
Q3 2019 Nov 01, 2019	BUY	$67.4 - $85.11 $3,302 - $4,170	49 Added 445.45%	60 $3,000
Q2 2019 Jul 23, 2019	SELL	$80.35 - $93.9 $6,428 - $7,512	-80 Reduced 87.91%	11 $0
Q1 2019 Apr 09, 2019	SELL	$84.2 - $98.62 $1,431 - $1,676	-17 Reduced 15.74%	91 $7,000
Q4 2018 Jan 28, 2019	SELL	$80.14 - $106.07 $78,216 - $103,524	-976 Reduced 90.04%	108 $9,000
Q3 2018 Oct 18, 2018	BUY	$93.92 - $105.72 $101,809 - $114,600	1,084 New	1,084 $105,000

Others Institutions Holding BMRN

# of Institutions

668

Shares Held

184M

Call Options Held

1.24M

Put Options Held

957K

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $10.8B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.

Account

Huntington National Bank Biomarin Pharmaceutical Inc Transaction History